Indus Biotech

Pune, India Founded: 1997 • Age: 29 yrs
Drugs for autoimmune, CNS, infectious, and lifestyle diseases are developed.

About Indus Biotech

Indus Biotech is a Healthcare company based in Pune (India) founded in 1997 by Ranjeet Palliyil Srinivasan. Drugs for autoimmune, CNS, infectious, and lifestyle diseases are developed. Indus Biotech has raised $5.27 million across 1 funding round. The company has 138 employees. Its Indian entity Indus Biotech Limited reported revenue of ₹71.42 Cr. Indus Biotech offers products and services including Testosurge®, Fenuflakes®, Vinomerix®, Torabolic®, and Sugaheal®. Its focus areas include Diversified Pharmaceuticals, Biopharma Outsourcing, CRO and Drug Discovery.

Company details

Founded in 1997, Indus Biotech operates as a drug discovery company in the biotechnology sector, based in Pune, India. Focus is placed on identifying and developing treatments for autoimmune, oncology, central nervous system, infectious, and lifestyle diseases. Current products encompass torabolic for mass building, testosurge for testosterone bioavailability enhancement, biocreat for creatine delivery to muscle tissue, and testofen for libido support. Operations emphasize research and product innovation.

  • Headquarters Pune, India
  • Employees 138
  • Founders Ranjeet Palliyil Srinivasan
  • Sectors
    Healthcare
  • Website category Health · Biotechnology and Pharmaceuticals
  • Phone
    •••• ••••
  • Website indusbiotech.com
  • Social LinkedIn
  • Legal Name Indus Biotech Limited
  • Date of Incorporation 16 Feb, 1995
  • Jurisdiction Pune, Maharashtra, India
Key Metrics
  • Annual Revenue
    ₹71.42 Cr

    FY 2025 · +2% YoY

  • Net Profit
    ₹3.68 Cr

    FY 2025 · 5% margin

  • EBITDA
    ₹10.88 Cr

    FY 2025 · 15% margin

  • Total Equity Funding
    $5.27M (USD)

    in 1 rounds

  • Latest Funding Round
    $5.27M (USD), Series A

    Jun 2007

  • Employee Count
    138

Products & Services of Indus Biotech

Indus Biotech offers a comprehensive portfolio of products and services, including Testosurge®, Fenuflakes®, Vinomerix®, Torabolic®, and Sugaheal®.

Testosurge®
Nutraceutical Ingredient

Increases testosterone levels through natural, clinically proven extracts.

Fenuflakes®
Food Ingredient

Supports blood sugar management with high-fiber fenugreek extract.

Vinomerix®
Antioxidant Extract

Provides grape seed extract for improved health and circulation benefits.

Torabolic®
Performance Enhancer

Boosts lean mass and strength via fenugreek-based formulation.

Sugaheal®
Blood Sugar Support

Helps maintain healthy glucose levels in diabetes management.

BreathMor®
Nasal Relief Product

Alleviates allergic rhinitis symptoms using cinnamon bark extract.

Funding Insights of Indus Biotech

Indus Biotech has successfully raised a total of $5.27M through 1 strategic funding round. The most recent funding activity was a Series A round of $5.27 million completed in June 2007. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $5.27M
  • Total Rounds 1
  • Last Round Series A — $5.27M
  • First Round $5.27M

    (Jun 2007)

All 1 funding rounds of Indus Biotech with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jun 2007$5.27MSeries A––
–

Board of directors of Indus Biotech Limited (Indus Biotech)

Indus Biotech Limited is the primary company behind Indus Biotech. The boards of the 2 registered companies of Indus Biotech currently have 9 directors; the longest-serving is Ranjeet Palliyil Srinivasan, appointed in 1995. 9 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Ranjeet Palliyil Srinivasan
DIN 00565528
Director16 Feb 199531 yrs 9 moIndus Biotech Limited
Sunil Dutt Bhaskaran
DIN 01499046
Managing Director16 Feb 199531 yrs 9 moIndus Biotech Limited
Rajan Ramaswamy Srinivasan
DIN 00485816
Director01 Jan 200125 yrs 10 moIndus Biotech Limited
Sanjeev Sekhar
DIN 07926201
Director01 Sep 20179 yrs 2 moTrigonella Labs Private Limited
Aditya Sunil Bhaskaran
DIN 07926202
Director01 Sep 20179 yrs 2 moTrigonella Labs Private Limited
Achyut Jayatirthrao Huilgol
DIN 07926200
CFO14 Mar 20188 yrs 8 moIndus Biotech Limited, Trigonella Labs Private Limited
Shrikant Jayawant Patil
DIN 01501715
Director15 Nov 20215 yrsIndus Biotech Limited
Anil Pratap Kumar
DIN 00466438
Director15 Nov 20215 yrsIndus Biotech Limited
Pankaj Mehra
DIN 00504916
Director26 Sep 20251 yr 1 moIndus Biotech Limited

People of Indus Biotech

1 people are tracked at Indus Biotech (1 in leadership); the tracked headcount is 138.

NameRoleGroup
FounderLeadership
Premium access

Complete people profiles for Indus Biotech

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Indus Biotech

Figures of Indus Biotech Limited, the primary company behind Indus Biotech, for FY 2025. Revenue was ₹71.42 Cr (+2% year on year). Net profit was ₹3.68 Cr (5% margin). EBITDA was ₹10.88 Cr (15% margin). Revenue has grown at a compounded annual rate of -10% over three years and -7% over five years.

  • ₹71.42 CrRevenue · FY 2025 · +2% YoY
  • ₹3.68 CrNet profit · 5% margin
  • ₹10.88 CrEBITDA · 15% margin
  • ₹10.48 CrPaid-up capital
  • 138Employees (provident fund records)
  • -10%Revenue CAGR, 3 years
  • -7%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Indus Biotech Limited are on its company page.

Premium access

Detailed financial statements for Indus Biotech

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of Indus Biotech

2 dated milestones of Indus Biotech across 10 years, from founding to its latest funding, stage changes and deals.

  1. Founded Indus Biotech is founded.
  2. Funding First funding round of $5.3M.

Web traffic of Indus Biotech

The website of Indus Biotech (indusbiotech.com) receives about 2.5K visits a month and ranks #3,248,517 among all websites worldwide, #4,264 in Biotechnology and Pharmaceuticals.

  • Monthly visits
    2.5K

    ▲ 3.6% vs previous month

  • Global rank
    #3,248,517

    among all websites

  • Category rank
    #4,264

    Health · Biotechnology and Pharmaceuticals

Similar websites

Websites whose visitors overlap most with Indus Biotech. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
jubilantbiosys.com
100%
12.2K#2,731,637View details
lupinworld.com
lupinworld.com
98%
–
martinandpleasance.com
58%
#1,148,115View details
geneombiotechnologies.com
39%
View details
ajaybiotech.com
39%
1.3K#11,484,262View details
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
Premium access

All 8 similar websites and full traffic analytics for Indus Biotech

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 8 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Biopharma Outsourcing & Drug Delivery

3 companies that operate in the same segment as Indus Biotech (Biopharma Outsourcing & Drug Delivery) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Developer of integrated contract research development and manufacturing services
2007Bengaluru, Karnataka, IndiaUSD 35.74 MUSD 226.38 M2,062
Pharmaceutical and biotechnology company
2005Hyderabad, Telangana, IndiaUSD 229.73 MUSD 726.15 M548
India's leading healthcare products distribution platform
2018Mumbai, Maharashtra, IndiaUSD 59.67 MUSD 702.49 M557
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Indus Biotech

Premium access

Complete news archive for Indus Biotech

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Indus Biotech

Indus Biotech was founded in 1997 and raised its 1st funding round 10 years after it was founded.

Indus Biotech is headquartered in Pune, India. It is registered at Pune, Maharashtra, India.

Indus Biotech is a funded company, having raised a total of $5.27M across 1 funding round to date. The company's 1st funding round was a Series A of $5.27M, raised on Jun 2007.

Indus Biotech has 138 employees.

The primary company behind Indus Biotech, Indus Biotech Limited, reported revenue of ₹71.42 Cr for FY 2025, up 2% year on year.

Founded in 1997, Indus Biotech operates as a drug discovery company in the biotechnology sector, based in Pune, India. Focus is placed on identifying and developing treatments for autoimmune, oncology, central nervous system, infectious, and lifestyle diseases. Current products encompass torabolic for mass building, testosurge for testosterone bioavailability enhancement, biocreat for creatine delivery to muscle tissue, and testofen for libido support. Operations emphasize research and product innovation.

Indus Biotech offers Testosurge®, Fenuflakes®, Vinomerix®, Torabolic®, and 2 more products and services.

Indus Biotech is associated with 2 legal entities: Indus Biotech Limited, Trigonella Labs Private Limited.

The legal entities of Indus Biotech currently have 10 directors, including Rajan Ramaswamy Srinivasan, Achyut Jayatirthrao Huilgol, Ranjeet Palliyil Srinivasan and others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available